These findings deepen our understanding of the effect of free fatty acids on the intestinal mucosal barrier integrity, which may help guide nutritional advice for newly diagnosed colitis patients and highlights the beneficial effects of IL-22 therapy beyond the pancreatic islets in obesity. This evidence concerns the gene IL22 and obesity due to melanocortin 4 receptor deficiency.